ライブラリ登録: Guest
Critical Reviews™ in Oncogenesis

年間 4 号発行

ISSN 印刷: 0893-9675

ISSN オンライン: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Neuroblastoma

巻 20, 発行 3-4, 2015, pp. 245-270
DOI: 10.1615/CritRevOncog.2015014033
Get accessGet access

要約

Neuroblastoma is the most common extracranial solid tumor in children. Since its first description some 150 years ago, its enigmatic clinical presentation has challenged clinicians and fascinated basic researchers. This article presents an overview of the key clinical features of neuroblastoma and current therapeutic approaches. It also highlights how our understanding of sympathoadrenal developmental biology, coupled with transcriptome analyses, next-generation sequencing, and genome-wide association and epigenetic studies, has illuminated critical signal transduction pathways involved in neuroblastoma tumorigenesis and identified therapeutically tractable targets for clinical development.

キーワード: neuroblastoma, MYCN, ALK, LIN28B, PHOX2B, NTRK
によって引用された
  1. Lin Xiaokun, Wu Dazhou, Chen Congde, Zheng Na, Clinical characteristics of adrenal tumors in children: a retrospective review of a 15-year single-center experience, International Urology and Nephrology, 49, 3, 2017. Crossref

  2. Liu Zhihui, Thiele Carol J., Molecular Genetics of Neuroblastoma, in Diagnostic and Therapeutic Nuclear Medicine for Neuroendocrine Tumors, 2017. Crossref

  3. Rauschert Ines, Aldunate Fabian, Preussner Jens, Arocena-Sutz Miguel, Peraza Vanina, Looso Mario, Benech Juan C., Agrelo Ruben, Ballestar Esteban, Promoter hypermethylation as a mechanism for Lamin A/C silencing in a subset of neuroblastoma cells, PLOS ONE, 12, 4, 2017. Crossref

  4. Lee Yueh Z., Oldan Jorge D., Fordham Lynn A., Pediatric Applications of Hybrid PET/MR Imaging, Magnetic Resonance Imaging Clinics of North America, 25, 2, 2017. Crossref

  5. Ahmed Atif A., Zhang Lei, Reddivalla Naresh, Hetherington Maxine, Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors, Pediatric Hematology and Oncology, 34, 3, 2017. Crossref

  6. Wiles Austin Blackburn, Karrs Jeremiah Xavier, Pitt Susan, Almenara Jorge, Powers Celeste N., Smith Steven Christopher, GATA3 is a reliable marker for neuroblastoma in limited samples, including FNA Cell Blocks, core biopsies, and touch imprints, Cancer Cytopathology, 125, 12, 2017. Crossref

  7. Nan Jiang, Guan Sun, Jin Xu, Jian Zhu, Linshan Fu, Jun Guo, Down-regulation of C-terminal binding protein 2 (CtBP2) inhibits proliferation, migration, and invasion of human SHSY5Y cells in vitro, Neuroscience Letters, 647, 2017. Crossref

  8. Lin Xiaokun, He Guorong , Chen Congde , Li Zhongrong , Clinical Characteristics of Peripheral Neuroblastic Tumors in Children: A Single-Center Experience of 43 Cases, Iranian Journal of Pediatrics, In Press, In Press, 2018. Crossref

  9. Wu Ji‐cheng, Jiang Hua‐mao, Yang Xiang‐hong, Zheng Hua‐chuan, ING5‐mediated antineuroblastoma effects of suberoylanilide hydroxamic acid, Cancer Medicine, 7, 9, 2018. Crossref

  10. Rodríguez-Nogales Carlos, Noguera Rosa, Couvreur Patrick, Blanco-Prieto María J., Therapeutic Opportunities in Neuroblastoma Using Nanotechnology, Journal of Pharmacology and Experimental Therapeutics, 370, 3, 2019. Crossref

  11. Zhao Qian, Jin Mei, Zhang Da-Wei, Zhao Wen, Wang Xi-Si, Yue Zhi-Xia, Duan Chao, Huang Cheng, Ma Xiao-Li, Serum Interleukin-6 Level and the rs1800795 Polymorphism in its Gene Associated with Neuroblastoma Risk in Chinese Children, Chinese Medical Journal, 131, 9, 2018. Crossref

  12. Calabrese Francesco Maria, Clima Rosanna, Pignataro Piero, Lasorsa Vito Alessandro, Hogarty Michael D., Castellano Aurora, Conte Massimo, Tonini Gian Paolo, Iolascon Achille, Gasparre Giuseppe, Capasso Mario, A comprehensive characterization of rare mitochondrial DNA variants in neuroblastoma, Oncotarget, 7, 31, 2016. Crossref

  13. Lodrini Marco, Sprüssel Annika, Astrahantseff Kathy, Tiburtius Daniela, Konschak Robert, Lode Holger N., Fischer Matthias, Keilholz Ulrich, Eggert Angelika, Deubzer Hedwig E., Using droplet digital PCR to analyze MYCN and ALK copy number in plasma from patients with neuroblastoma, Oncotarget, 8, 49, 2017. Crossref

  14. Peitz Constantin, Sprüssel Annika, Linke Rasmus B., Astrahantseff Kathy, Grimaldi Maddalena, Schmelz Karin, Toedling Joern, Schulte Johannes H., Fischer Matthias, Messerschmidt Clemens, Beule Dieter, Keilholz Ulrich, Eggert Angelika, Deubzer Hedwig E., Lodrini Marco, Multiplexed Quantification of Four Neuroblastoma DNA Targets in a Single Droplet Digital PCR Reaction, The Journal of Molecular Diagnostics, 22, 11, 2020. Crossref

  15. Furlanetto Gislaine, Spagnol Fabiane, Alegretti Ana Paula, Farias Mariela Granero, Soares Victor Jablonski, Daudt Liane Esteves, Loss Jiseh Fagundes, Scroferneker Maria Lúcia, Michalowski Mariana Bohns, Flow cytometry as a diagnostic tool in neuroblastoma, Journal of Immunological Methods, 498, 2021. Crossref

  16. Cerci Juliano J., Etchebehere Elba C., Nadel Helen, Brink Anita, Bal Chandrasekhar S., Rangarajan Venkatesh, Pfluger Thomas, Kagna Olga, Alonso Omar, Begum Fatima K., Mir Kahkashan Bashir, Magboo Vincent P., Menezes Leon J., Paez Diana, Pascual Thomas N., Is True Whole-Body 18F-FDG PET/CT Required in Pediatric Lymphoma? An IAEA Multicenter Prospective Study, Journal of Nuclear Medicine, 60, 8, 2019. Crossref

  17. Ozen Karakus Ozlem, Godugu Kavitha, Mousa Shaker A., Discovery of dual targeting PEGylated BG-P1600-TAT to norepinephrine transporter (NET) and thyrointegrin αvβ3 in the treatment of neuroblastoma, Bioorganic & Medicinal Chemistry, 43, 2021. Crossref

  18. Chen Ming, Zhao Meng, Hou Yan, Zhu Bin, Expression of lncRNA CCAT2 in children with neuroblastoma and its effect on cancer cell growth, Molecular and Cellular Biochemistry, 476, 4, 2021. Crossref

  19. Szymansky Annabell, Kruetzfeldt Louisa-Marie, Heukamp Lukas C., Hertwig Falk, Theissen Jessica, Deubzer Hedwig E., Willing Eva-Maria, Menon Roopika, Fuchs Steffen, Thole Theresa, Schulte Stefanie, Schmelz Karin, Künkele Annette, Lang Peter, Fuchs Jörg, Eggert Angelika, Eckert Cornelia, Fischer Matthias, Henssen Anton G., Rodriguez-Fos Elias, Schulte Johannes H., Neuroblastoma Risk Assessment and Treatment Stratification with Hybrid Capture-Based Panel Sequencing, Journal of Personalized Medicine, 11, 8, 2021. Crossref

  20. Lazic Daria, Kromp Florian, Rifatbegovic Fikret, Repiscak Peter, Kirr Michael, Mivalt Filip, Halbritter Florian, Bernkopf Marie, Bileck Andrea, Ussowicz Marek, Ambros Inge M., Ambros Peter F., Gerner Christopher, Ladenstein Ruth, Ostalecki Christian, Taschner-Mandl Sabine, Landscape of Bone Marrow Metastasis in Human Neuroblastoma Unraveled by Transcriptomics and Deep Multiplex Imaging, Cancers, 13, 17, 2021. Crossref

  21. Fetahu Irfete S., Taschner-Mandl Sabine, Neuroblastoma and the epigenome, Cancer and Metastasis Reviews, 40, 1, 2021. Crossref

  22. Schmelz Karin, Toedling Joern, Huska Matt, Cwikla Maja C., Kruetzfeldt Louisa-Marie, Proba Jutta, Ambros Peter F., Ambros Inge M., Boral Sengül, Lodrini Marco, Chen Celine Y., Burkert Martin, Guergen Dennis, Szymansky Annabell, Astrahantseff Kathy, Kuenkele Annette, Haase Kerstin, Fischer Matthias, Deubzer Hedwig E., Hertwig Falk, Hundsdoerfer Patrick, Henssen Anton G., Schwarz Roland F., Schulte Johannes H., Eggert Angelika, Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions, Nature Communications, 12, 1, 2021. Crossref

  23. Rickman David S., Schulte Johannes H., Eilers Martin, The Expanding World of N-MYC–Driven Tumors, Cancer Discovery, 8, 2, 2018. Crossref

  24. Bierbrauer Annika, Jacob Maureen, Vogler Meike, Fulda Simone, A direct comparison of selective BH3-mimetics reveals BCL-XL, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastoma, British Journal of Cancer, 122, 10, 2020. Crossref

  25. Speleman Frank, Park Julie R., Henderson Tara O., Neuroblastoma: A Tough Nut to Crack, American Society of Clinical Oncology Educational Book, 36, 2016. Crossref

  26. Singh Shivendra, Quarni Waise, Goralski Maria, Wan Shibiao, Jin Hongjian, Van de Velde Lee-Ann, Fang Jie, Wu Qiong, Abu-Zaid Ahmed, Wang Tingting, Singh Ravi, Craft David, Fan Yiping, Confer Thomas, Johnson Melissa, Akers Walter J., Wang Ruoning, Murray Peter J., Thomas Paul G., Nijhawan Deepak, Davidoff Andrew M., Yang Jun, Targeting the spliceosome through RBM39 degradation results in exceptional responses in high-risk neuroblastoma models, Science Advances, 7, 47, 2021. Crossref

  27. Sun Ming, Veschi Veronica, Bagchi Sukriti, Xu Man, Mendoza Arnulfo, Liu Zhihui, Thiele Carol J., Targeting the Chromosomal Passenger Complex Subunit INCENP Induces Polyploidization, Apoptosis, and Senescence in Neuroblastoma, Cancer Research, 79, 19, 2019. Crossref

  28. Altini Claudio, Villani Maria F., Di Giannatale Angela, Cassano Bartolomeo, Pizzoferro Milena, Serra Annalisa, Castellano Aurora, Cannatà Vittorio, Garganese Maria C., Tandem high-dose 131I-MIBG therapy supported by dosimetry in pediatric patients with relapsed-refractory high-risk neuroblastoma: the Bambino Gesu’ Children’s Hospital experience, Nuclear Medicine Communications, 43, 2, 2022. Crossref

  29. Fang Yuan, Zhang Ye, Dong Rui, Wang Yi-zhen, Chen Lian, Chen Gong, A Case Series of Pediatric Intestinal Ganglioneuromatosis With Novel Phenotypic and Genotypic Profile, Frontiers in Medicine, 9, 2022. Crossref

  30. Veschi Veronica, Liu Zhihui, Voss Ty C., Ozbun Laurent, Gryder Berkley, Yan Chunhua, Hu Ying, Ma Anqi, Jin Jian, Mazur Sharlyn J., Lam Norris, Souza Barbara K., Giannini Giuseppe, Hager Gordon L., Arrowsmith Cheryl H., Khan Javed, Appella Ettore, Thiele Carol J., Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma, Cancer Cell, 31, 1, 2017. Crossref

  31. Olsen Thale Kristin, Dyberg Cecilia, Embaie Bethel Tesfai, Alchahin Adele, Milosevic Jelena, Ding Jane, Otte Jörg, Tümmler Conny, Hed Myrberg Ida, Westerhout Ellen M., Koster Jan, Versteeg Rogier, Ding Han-Fei, Kogner Per, Johnsen John Inge, Sykes David B., Baryawno Ninib, DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma, JCI Insight, 7, 17, 2022. Crossref

Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集 価格及び購読のポリシー Begell House 連絡先 Language English 中文 Русский Português German French Spain